The 2023-2028 Outlook for Indwelling Catheters in China
US$ 595.00
This study covers the latent demand outlook for indwelling catheters across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), muni...
August 2022
185 pages
The 2023-2028 Outlook for Infant Formula Packaging in China
US$ 595.00
This study covers the latent demand outlook for infant formula packaging across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet),...
August 2022
185 pages
The 2023-2028 Outlook for Infant Formula Testing in China
US$ 595.00
This study covers the latent demand outlook for infant formula testing across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Infant Formulas in China
US$ 595.00
This study covers the latent demand outlook for infant formulas across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipal...
August 2022
185 pages
The 2023-2028 Outlook for Infant Incubators in China
US$ 595.00
This study covers the latent demand outlook for infant incubators across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municip...
August 2022
185 pages
The 2023-2028 Outlook for Infant Nutrition in China
US$ 595.00
This study covers the latent demand outlook for infant nutrition across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipa...
August 2022
185 pages
The 2023-2028 Outlook for Infectious Disease Drugs in China
US$ 595.00
This study covers the latent demand outlook for infectious disease drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet),...
August 2022
185 pages
The 2023-2028 Outlook for Infectious Diseases in China
US$ 595.00
This study covers the latent demand outlook for infectious diseases across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Infertility Drugs in China
US$ 595.00
This study covers the latent demand outlook for infertility drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municip...
August 2022
185 pages
The 2023-2028 Outlook for Infertility Treatments in China
US$ 595.00
This study covers the latent demand outlook for infertility treatments across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Inflatable Toys in China
US$ 595.00
This study covers the latent demand outlook for inflatable toys across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipal...
August 2022
185 pages
The 2023-2028 Outlook for Inflation Devices in China
US$ 595.00
This study covers the latent demand outlook for inflation devices across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municip...
August 2022
185 pages
The 2023-2028 Outlook for Influenza Drugs in China
US$ 595.00
This study covers the latent demand outlook for influenza drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipal...
August 2022
185 pages
The 2023-2028 Outlook for Influenza in China
US$ 595.00
This study covers the latent demand outlook for influenza across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities...
August 2022
185 pages
The 2023-2028 Outlook for Influenza Medications in China
US$ 595.00
This study covers the latent demand outlook for influenza medications across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mun...
August 2022
185 pages
The 2023-2028 Outlook for Influenza Testing in China
US$ 595.00
This study covers the latent demand outlook for influenza testing across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municip...
August 2022
185 pages
The 2023-2028 Outlook for Influenza Vaccines in China
US$ 595.00
This study covers the latent demand outlook for influenza vaccines across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munici...
August 2022
185 pages
The 2023-2028 Outlook for Ingredients in China
US$ 595.00
This study covers the latent demand outlook for ingredients across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalitie...
August 2022
185 pages
The 2023-2028 Outlook for Inhalable Drugs in China
US$ 595.00
This study covers the latent demand outlook for inhalable drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipal...
August 2022
185 pages
